Mark Matzopoulos

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Mark Matzopoulos is an author at Vertex Pharmaceuticals (United States) specializing in multiple-period crossover designs, diabetes mellitus, and diabetes control.

Publications per year

2021–2021

Publications

Ultra rapid lispro (URLi) shows faster pharmacokinetics and reduces postprandial glucose excursions versus <scp>H</scp> umalog® in patients with type 2 diabetes mellitus in a randomized, controlled crossover meal test early‐phase study

Jennifer Leohr, Christof Kazda, Rong Liu et al. · Diabetes Obesity and Metabolism · 2021 · 13 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

1–1 of 1